Quantification of G-6-PD enzyme activity in newborns is the most effective approach for the management of G-6-PD deficiency to prevent severe jaundice and acute hemolysis. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.